Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

Pralmorelin (GHRP-2)vsCJC-1295 with DAC

A powerful hexapeptide that stimulates growth hormone release—used clinically in Japan for GH testing and studied for healing and anti-inflammatory effects.

Long-acting growth hormone releaser that works around the clock to boost your body's natural GH production with just one or two injections per week.

Growth HormoneGrowth Hormone

At a Glance

Quick
comparison

Dose Range

Pralmorelin (GHRP-2)

100–300 mcg

CJC-1295 with DAC

1000–2000 mcg

Frequency

Pralmorelin (GHRP-2)

Once daily

CJC-1295 with DAC

Twice weekly

Administration

Pralmorelin (GHRP-2)

Subcutaneous injection

CJC-1295 with DAC

Subcutaneous injection

Cycle Length

Pralmorelin (GHRP-2)

4-6 weeks

CJC-1295 with DAC

8-12 weeks

Onset Speed

Pralmorelin (GHRP-2)

Rapid (hours to days)

CJC-1295 with DAC

Moderate (1-2 weeks)

Evidence Level

Pralmorelin (GHRP-2)

Limited human trials

CJC-1295 with DAC

Moderate human trials (Phase 1-2)

Efficacy

Benefit
ratings

Pralmorelin (GHRP-2)
CJC-1295 with DAC

Muscle & Performance Enhancement

Pralmorelin (GHRP-2)90%
CJC-1295 with DAC0%

Injury Recovery & Healing

Pralmorelin (GHRP-2)85%
CJC-1295 with DAC0%

Diagnostic Clinical Use

Pralmorelin (GHRP-2)95%
CJC-1295 with DAC0%

GH Elevation

Pralmorelin (GHRP-2)0%
CJC-1295 with DAC92%

Convenience

Pralmorelin (GHRP-2)0%
CJC-1295 with DAC95%

Recovery Support

Pralmorelin (GHRP-2)0%
CJC-1295 with DAC88%

Technical Data

Compound
specifications

Pralmorelin (GHRP-2)

Molecular Formula

C45H55N9O6

Molecular Weight

818.0 g/mol

Half-Life

15-60 minutes

Bioavailability

~100% (subcutaneous injection)

CAS Number

158861-67-7

CJC-1295 with DAC

Molecular Formula

C165H269N47O46

Molecular Weight

3647.28 g/mol

Half-Life

6-8 days

Bioavailability

~100% (subcutaneous)

CAS Number

863288-34-0

Protocols

Dosing
tiers

Pralmorelin (GHRP-2)

starting

50-100 mcg

Once daily or twice weekly

1-2 weeks

Begin conservatively to assess individual responsiveness and side effect tolerance. Administer subcutaneously in abdomen or thigh.

standard

100-200 mcg

1-3 times daily

4-6 weeks

Most individuals find optimal response and tolerability in this range. Typical use case for GH axis stimulation and recovery support.

advanced

200-300 mcg

2-3 times daily

4-8 weeks

Higher doses used in intensive research or competitive athletic settings. Requires previous GHRP experience and close monitoring. Risk-benefit ratio increases.

CJC-1295 with DAC

starting

1000 mcg (1 mg)

Once weekly

2-4 weeks

Start with once weekly dosing to assess tolerance and gauge your individual response to the peptide before increasing.

standard

1000-2000 mcg (1-2 mg)

Twice weekly

8-12 weeks

The most common protocol used in research and practice. Provides sustained GH elevation throughout the week with the long half-life.

advanced

2000 mcg (2 mg)

Twice weekly

12+ weeks

Higher dosing for maximum GH stimulation. Monitor for side effects like water retention and adjust as needed. Extended cycles require periodic breaks.

Applications

Best
suited for

Pralmorelin (GHRP-2)

Athletes and Fitness Enthusiasts

If you're serious about lean muscle gains and recovery, pralmorelin directly stimulates GH release—one of the body's most powerful anabolic hormones. Most athletes in research settings use 100-200 mcg for faster muscle repair and improved performance.

Individuals Recovering from Injury

Recent animal studies show GHRP-2 reduces inflammation and speeds tendon-bone healing. If you're dealing with sports injuries, rotator cuff issues, or fractures, this peptide's anti-inflammatory profile may accelerate recovery when combined with proper rehab.

Those Seeking Diagnostic GH Testing

If your doctor suspects growth hormone deficiency, pralmorelin is the gold-standard diagnostic tool in Japan and many countries. A single injection stimulates GH release, allowing physicians to assess your pituitary function safely and accurately.

Peptide Research Enthusiasts

Pralmorelin is one of the most extensively studied GHRPs worldwide. If you're exploring peptide protocols and understand research-grade products, this is a powerful tool for understanding how your GH axis responds to stimulation.

CJC-1295 with DAC

Growth Hormone Optimization

CJC-1295 with DAC excels at providing a sustained, steady elevation of growth hormone levels. Unlike shorter-acting peptides that create brief spikes, the DAC modification keeps GH elevated for days, mimicking a more youthful hormone profile.

Muscle Building and Recovery

By increasing both GH and IGF-1 levels, this peptide supports protein synthesis and muscle repair. Users often notice improved recovery between workouts and better ability to build and maintain lean muscle mass.

Anti-Aging and Longevity

Growth hormone naturally declines with age, contributing to many signs of aging. CJC-1295 with DAC helps restore more youthful GH levels, potentially supporting better skin quality, energy levels, and overall vitality.

Body Composition Improvement

The combination of increased GH and IGF-1 promotes fat metabolism while preserving muscle tissue. Many users experience gradual fat loss, particularly in stubborn areas, while maintaining or building lean mass.

Convenient Weekly Dosing

Unlike peptides requiring daily or twice-daily injections, the extended half-life of CJC-1295 with DAC means just one or two injections per week provide continuous benefits. Ideal for those who want results without daily protocols.

Safety Profile

Side
effects

Pralmorelin (GHRP-2)

Common

  • Facial flushing
  • Transient headache
  • Increased appetite
  • Temporary dizziness or lightheadedness

Uncommon

  • Carpal tunnel-like sensations
  • Joint or muscle aches
  • Sleep quality changes

Serious

  • Severe allergic reaction (anaphylaxis)

CJC-1295 with DAC

Common

  • Injection site reactions
  • Water retention
  • Flushing
  • Tingling sensation

Uncommon

  • Headaches
  • Fatigue or lethargy
  • Joint discomfort

Serious

  • Carpal tunnel symptoms
  • Blood glucose elevation

Research Status

Safety
& evidence

Pralmorelin (GHRP-2)

Evidence Level

Limited human trials

FDA Status

Research compound

Safety Overview

Pralmorelin (GHRP-2) has been safely used in diagnostic settings in Japan for decades and is well-tolerated in most individuals when used at appropriate doses. The peptide is synthetic and chemically stable, with low immunogenicity risk. However, it is NOT FDA approved and should only be used under medical supervision or within research protocols. Long-term safety data in healthy humans is limited.

Contraindications

  • xActive malignancy or unresolved cancer history
  • xUncontrolled hypertension or severe cardiovascular disease
  • xPregnancy or breastfeeding
  • xAcute infection or sepsis
  • xUncontrolled diabetes

CJC-1295 with DAC

Evidence Level

Moderate human trials (Phase 1-2)

FDA Status

Research compound

Safety Overview

CJC-1295 with DAC was evaluated in Phase 1-2 human clinical trials where it demonstrated a generally favorable safety profile. The most common adverse events were mild injection site reactions including temporary pain, swelling, and redness. No serious adverse events were reported in the published clinical studies. The compound was being developed for HIV-associated lipodystrophy before the program was discontinued.

Contraindications

  • xActive cancer or history of malignancy
  • xPregnancy or breastfeeding
  • xPituitary tumors or disorders
  • xDiabetic retinopathy
  • xUncontrolled diabetes

Decision Guide

Which is
right for you?

Choose Pralmorelin (GHRP-2) if...

  • Athletes seeking enhanced recovery and lean mass gains
  • Individuals with suspected GH deficiency (diagnostic use)
  • Recovery from tendon or bone injuries
  • Those wanting to test GH axis responsiveness

Choose CJC-1295 with DAC if...

  • Boosting natural growth hormone production
  • Building lean muscle mass
  • Improving body composition
  • Anti-aging and longevity